CSL CEO on Financial Results, Business Outlook

Feb. 12 (Bloomberg) -- Paul Perreault, chief executive officer of CSL Ltd., Australia's biggest pharmaceutical company, talks about its financial results and business outlook. CSL reported a 3.4 percent increase in first-half profit, helped by surging sales of an antidote for the blood-thinner warfarin. Perreault speaks from Melbourne with Angie Lau on Bloomberg Television's "First Up." (Source: Bloomberg)
Why the RBA Will Leave Rates Unchanged: Lakos
24:33 - Macquarie's Martin Lakos explains why he thinks the Reserve Bank of Australia will leave rates unchanged. He speaks with Bloomberg's Shery Ahn on "Trending Business." (Source: Bloomberg)
  • Over 100 Questioned in Xi’s Graft Inquiry
  • Westpac CFO Says Bank 'Strongly Capitalized' for Risks
  • Euro’s April Rally Biggest in Five Years